Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meliorum Technologies is a private U.S. nanomaterials company that designs and manufactures custom nanoparticles, nanomaterial dispersions, nanoinks, and engineered nanofluids for industrial and research customers. Its core offerings include silicon nanoparticles, gold nanoparticles, cerium oxide nanoparticles, zinc oxide nanoparticles, other metal and metal oxide nanoparticles, and application-specific precursor formulations. The company emphasizes customizable particle properties, surface functionalization, solvent compatibility, and scalable production from research quantities to larger commercial volumes. Meliorum appears to operate primarily as a specialty materials supplier rather than a therapeutic biotech or pharmaceutical developer, with customers spanning university research and industrial manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meliorum Technologies.